Adverse impact of fibrin clot inhibitors on intravesical bacillus Calmette-Guerin therapy for superficial bladder tumors.
暂无分享，去创建一个
[1] L. Kavoussi,et al. Results of 6 weekly intravesical bacillus Calmette-Guerin instillations on the treatment of superficial bladder tumors. , 1988, The Journal of urology.
[2] D. Martin,et al. Fibronectin enhances healing of excised wounds in rats. , 1988, Archives of dermatology.
[3] T. Ratliff,et al. Intravesical Bacillus Calmette-Guérin therapy for murine bladder tumors: initiation of the response by fibronectin-mediated attachment of Bacillus Calmette-Guérin. , 1987, Cancer research.
[4] P. Schellhammer,et al. Bacillus Calmette-Guerin for superficial transitional cell carcinoma of the bladder. , 1986, The Journal of urology.
[5] M. Melamed,et al. Long-term effect of intravesical bacillus Calmette-Guerin on flat carcinoma in situ of the bladder. , 1986, The Journal of urology.
[6] D. Lamm,et al. Bladder cancer immunotherapy. , 1982, The Journal of urology.
[7] S. Brosman. Experience with bacillus Calmette-Guerin in patients with superficial bladder carcinoma. , 1982, The Journal of urology.
[8] L. Kavoussi,et al. Fibronectin-mediated Calmette-Guerin bacillus attachment to murine bladder mucosa. Requirement for the expression of an antitumor response. , 1990, The Journal of clinical investigation.
[9] V. Laudone,et al. Superficial bladder cancer treated with bacillus Calmette-Guerin: a multivariate analysis of factors affecting tumor progression. , 1989, The Journal of urology.